Diagnostica Stago AustraliaHaemostasis and Thrombosis Solutions

Stago was a pharmaceutical laboratory, founded in 1945, which now operates in the In Vitro Diagnosis (IVD) industry, wholly dedicated to the exploration of haemostasis and thrombosis. From Research & Development and Production to Logistics, Marketing, Sales and International Distribution, Stago remains in control of its strategy at all levels. Certified ISO 13485, ISO 9001 and ISO 14001 for its main reagent manufacturing plant. the group’s industrial activities are mostly concentrated in France. Its geographical expansion has led to opening R&D and production centers in the USA, Netherlands, Germany, Ireland and China. Ever since our American subsidiary was established in 1985, our distribution network grew considerably throughout the world. Since 2003, 17 new affiliates have been opened: China (2003), United Kingdom (2005), Dubai (2007), Australia/New Zealand and Canada (2008), Hong-Kong (2011), Germany, Austria, Spain, Italy, Portugal, Switzerland, Belgium, Netherlands (all opened in 2012), India (2014), Brazil (2016) and Turkey (2017). The companies belonging to the Stago Group are: Diagnostica Stago, Agro-Bio, BioCytex, DSRV, Hemosonics, Synapse, Tcoag and Thrombinoscope. With over 350 marketed products, Stago is a worldwide reference in Haemostasis and a 1st class partner for biomedical laboratories. Specialised in the fields of Haemostasis and Thrombosis, Stago invests in research and innovation to develop new and better performing reagents, systems and solutions. With 60 years of experience, Stago has acquired a charismatic image in Haemostasis and is well recognised among the international scientific world.